The scientific intelligence layer powering life sciences deals
- SOC II aligned

Expert scientific judgment, delivered at AI scale
Prudentia brings together expert-developed frameworks, AI trained on drug development, and a unified evidence base to produce outputs grounded in science and ready for decision-making.
Centralized evidence
Unify fragmented data sources into a single, connected evidence base
- Securely connect to all necessary data sources
- Integrate public, proprietary, and internal datasets
- Organize all evidence within your company-specific system
Scientific diligence frameworks
Apply expert-developed frameworks to evaluate assets consistently
- Assess biological mechanism validity and plausibility
- Evaluate translational, regulatory, and clinical risk
- Model pTRS, NPV, and development scenarios
AI reasoning, grounded in evidence
Scale scientific reasoning across deals
- Models trained for therapeutic area and modalities, across drug development life cycle
- AI agents that understand drug development risks and opportunities
- End-to-end data provenance, with human-in-the-loop validation
Built by people who have been on every side of the table
Deep expertise across drug development, clinical strategy, and deal execution. This experience shapes the scientific frameworks behind every Prudentia evaluation.
Meet the teamMeet the team$0B+
Deal value across team experience
0+
Assets evaluated
0+
Drugs brought to market including Keytruda, Celebrex, Chimera, and more
A trusted third party between buyer and seller
Life sciences dealmaking involves some of the most sensitive data in the industry. Prudentia operates as the connective intelligence layer between pharma, biotech, VDR, and deal team, with every role bounded and every handoff disclosed.
Visit our Trust CenterVisit our Trust Center- SOC II aligned
- AWS-hosted
Secure Private Infrastructure
Single-tenant deployment with your data siloed and never shared across customers
Granular access controls
SSO integration with granular access controls and permissions
Data protected end-to-end
Encryption at rest and in transit, with complete audit trails
Built-in compliance
Your data is never used to train models, aligned with ISO/IEC 42001:2023
Built for every party in the deal
Deals move faster when every party at the table is working from the same protected evidence.
Pharma
Evaluate more assets with greater consistency. Apply expert diligence frameworks at scale, with AI reasoning grounded in scientific evidence and full data provenance across every deal.
I’m in pharmaBiotech
Make your asset legible to the buyers who matter. Profile, benchmark, and position using the same evaluation lens pharma BD applies, then share on your terms with verified counterparties.
I’m at a biotechDeal teams
Move transactions forward with confidence. From scientific staging and buyer matching to NDA management, diligence coordination, and term sheet support.